This program is provided by RxSchool.
This program has no commercial support. 

Course Overview

Many medications place patients at increased risk for osteoporosis. Join RxSchool for an informative presentation on Drug-Induced Osteoporosis. This course presents material on medications that place your patients at risk how supplemental agents can help alleviate a portion of the risk and the pharmacist’s role is helping patients manage this condition.

Planning to Share a Computer During This Event?

Remember each person must register individually before the event. Once registered, please email info@rxschool.com and provide us with the names of the persons who will be sharing a computer for our ACPE records.

Learning Objectives and Target Audience:

Target Audience: Pharmacists At the conclusion of this continuing education lesson, the pharmacist will be able to: Describe the epidemiology, socioeconomic impact and pathophysiology of osteoporosis. List common risk factors and medications that is associated with an increased incidence of developing osteoporosis. Discuss the standards for osteoporosis prophylaxis and treatment based on bone densitometry readings. Discuss the proposed mechanisms of drug-induced bone demineralization. Discuss recommendations that pharmacists can make to limit drug effects.

Faculty:

Darrell Hulisz, RPh, PharmD Associate Professor, Department of Family Medicine Case Western Reserve University, School of Medicine Associate Clinical Professor of Pharmacy Practice Ohio Northern University, College of Pharmacy

Faculty Disclosure:

RxSchool has a Full and Fair Disclosure Policy that requires course faculty to communicate any real or apparent commercial affiliations related to the content of their presentations/materials. Darrell Hulisz has no conflicts to disclose.

You must attend the entire session and complete an evaluation in order to receive your Statement of Credit.